Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280825 · ClinicalTrials.gov registry record
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
A clinical trial of Hepatitis C and Heart Diseases, sponsored by University of Chicago.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT01280825 is a study of Hepatitis C and Heart Diseases that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,200 participants, below the 1,879-participant average among 106 other Hepatitis C trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01280825, a study of Hepatitis C and Heart Diseases, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Conditions Studied
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2011-01-14 |
| Est. Completion | 2027-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01280825
The ClinicalTrials.gov registry entry for NCT01280825 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,879-participant average among 106 other Hepatitis C trials with a reported enrollment target (36% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01280825 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01280825 about?
NCT01280825 is a clinical study titled "The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing". The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be mad...
What is the current status of trial NCT01280825?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2011-01-14. Estimated completion is 2027-12-14.
What conditions does trial NCT01280825 study?
This clinical trial studies the following conditions: Hepatitis C, Heart Diseases, Inflammatory Bowel Diseases, Autoimmune Disease, Blood Coagulation Disorders.
Who is sponsoring clinical trial NCT01280825?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01280825 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.